Mobile Menu - OpenMobile Menu - Closed

Letter to FDA Regarding Heparin Contamination Crisis

Mar 15, 2017

Excerpt: “The Committee on Energy and Commerce continues to examine the heparin contamination crisis from 2007-2008 to help improve the Food and Drug Administration’s (FDA) strategy in combating economically-motivated adulteration of medical and food products imported to the U.S.”

To read a copy of the letter, click here.